Linezolid Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Linezolid Dosing Strategies in Drug-Resistant TB
Conditions:   Tuberculosis, Multidrug-Resistant;   Tuberculosis;   Tuberculosis, Pulmonary Interventions:   Drug: Linezolid 600 mg;   Drug: Linezolid 1200 mg (QD);   Drug: Linezolid 1200 mg (TIW);   Drug: Bedaquiline 200 mg;   Drug: Bedaquiline 100 mg;   Drug: Delamanid 300 mg;   Drug: Clofazimine 300 mg;   Drug: Clofazimine 100 mg Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials

Imipenem, Cilastatin Sodium, and Relebactam Monohydrate for the Treatment of Cancer Patients With Febrile Neutropenia
Conditions:   Hematopoietic and Lymphoid Cell Neoplasm;   Malignant Solid Neoplasm Interventions:   Drug: Cefepime;   Drug: Imipenem/cilastatin-relebactam;   Drug: Daptomycin;   Drug: Linezolid;   Drug: Meropenem;   Drug: Piperacillin-Tazobactam;   Drug: Vancomycin Sponsor:   M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2021 Category: Research Source Type: clinical trials